Skip to content

Acupressure of the ear for fatigue, sleep problems and anxiety in cancer patients treated with chemotherapy

Auricular acupressure for cancer-related fatigue, sleep disturbance and anxiety in lung cancer patients undergoing chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16408424
Enrollment
75
Registered
2018-05-10
Start date
2016-12-01
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, sleep disturbance and anxiety in lung cancer patients with no severe complications Mental and Behavioural Disorders

Interventions

Those patients who met the study criteria were randomly assigned to one of three groups using computer-generated numbers. Group A: auricular acupressure using Semen Vaccariae (SV, seed
the only difference was that magnetic beads were used in group B in place of SV. Group C: routine care Patients received routine care during hospitalization, and after

Sponsors

Suzhou Municipal Science and Technology Bureau
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years 2. Receiving conventional chemotherapy for lung cancer 3. Diagnosed with CRF using the diagnostic standards of the International Statistical Classification of Diseases and Related Health Problems 10th Revision and showed CRF =4 on a 0-10 numerical rating scale 4. No infection, injury or ulcers around the acupoint 5. No previous participation in AA or any fatigue-related intervention 6. No cognitively impairment 7. Willing to participate

Exclusion criteria

Exclusion criteria: Patients who had pleural effusion and other severe complications (such as severe anemia, severe organic diseases or dysfunction of heart, brain, or kidney) were excluded

Design outcomes

Primary

MeasureTime frame
Cancer-related fatigue (CRF) was assessed by the Cancer Fatigue Scale - Chinese version (CFS-C) using a numerical rating scale ranging from 0 to 10, with 10 indicating severe CRF and =4 indicating clinically significant fatigue. CRF was measured at baseline and at the end of the whole intervention, i.e. after the patients received three cycles of therapy.

Secondary

MeasureTime frame
1. Sleep quality and quantity in the past month was assessed using the Pittsburgh Sleep Quality Index (PSQI) 2. Anxiety was assessed using the Self-rating Anxiety Scale (SAS) Sleep disturbance and anxiety were measured at baseline and at the end of the whole intervention, i.e. after the patients received three cycles of therapy.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026